Carotid ultrasound may improve CVD risk assessment in patients with inflammatory skin condition

Carotid ultrasound improves the cardiovascular risk stratification of individuals with the skin condition hidradenitis suppurativa (HS), according to a study published Jan. 4 in PLOS One.

As part of the study, researchers performed carotid ultrasound on 60 HS patients without a history of cardiovascular events, diabetes or chronic kidney disease, according to Cardiovascular Business. They also assessed each patient’s risk for cardiovascular disease based on the common predictive tool, the Framingham Risk Score (FRS). The objective of the ultrasounds was to test for atherosclerotic plaques.

“Based on our data, we recommended the use of carotid (ultrasound) in HS-patients with an intermediate risk for cardiovascular disease,” lead author Marcos Antonio Gonzalez-Lopez, MD, PhD, and colleagues wrote in the study. “Low-risk HS individuals aged 50 years and older, active smokers, with severe or longstanding disease (less than 20 years) should be considered for carotid ultrasonography assessment according to an individualized clinical evaluation.”

Read more at Cardiovascular Business: